AnaptysBio, Inc. Share Price
NASDAQ: ANAB | Small CapAnaptysBio, Inc. Stock Performance
AnaptysBio, Inc. Share Price Today
As of 30 October 2026, AnaptysBio, Inc.'s share price is $48.62. The stock opened at $50.85, compared to its previous close of $50.50. During today's trading session, AnaptysBio, Inc.'s share price traded between $48.43 and $50.96, with an average price of $49.70. Over the past 52 weeks, the stock has recorded a high of $72.93 and a low of $30.50. In terms of performance, AnaptysBio, Inc.'s share price has declined by 26.04% over the last six months and is up 32.82% on a year-on-year basis.
AnaptysBio, Inc. Share Price Chart
AnaptysBio, Inc. Quarterly Profit & Loss
All figures in USD
AnaptysBio, Inc. Annual Profit & Loss
All figures in USD
About AnaptysBio, Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
AnaptysBio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $50.98 | $48.46 | -3.82% |
Sep 2026 | $56.96 | $50.38 | -12.09% |
Aug 2026 | $51.98 | $57.31 | +7.57% |
Jul 2026 | $66.59 | $53.28 | -21.01% |
Jun 2026 | $54.54 | $67.45 | +21.01% |
May 2026 | $66.31 | $55.74 | -15.21% |
Apr 2026 | $56.16 | $65.74 | +18.40% |
Mar 2026 | $54.22 | $55.52 | +1.06% |
Feb 2026 | $47.86 | $54.94 | +15.88% |
Jan 2026 | $48.57 | $47.41 | -2.24% |
Dec 2025 | $41.94 | $48.49 | +16.03% |
Nov 2025 | $36.44 | $41.80 | +14.18% |